RNA | MedPath Search

Clinical Trials

Find the latest clinical trials by condition, location & phase

Drugs Monographs

Browse and search for drug monographs and related information

Approved pharmaceutical products by global regulatory authorities

Explore a comprehensive list of organizations, including their profiles and details

Latest updates on clinical trials, pharmaceuticals, and healthcare companies

|

Filters

Study Phase

Early Phase 1

Phase 1

Phase 1/2

Phase 2

Phase 2/3

Phase 3

Phase 4

Not Applicable

Recruitment Status

Recruiting

Not yet recruiting

Active, not recruiting

Completed

Suspended

Terminated

Withdrawn

Study Type

Interventional

Observational

Expanded Access

Others

Eligibility Sex

All

Female

Male

Healthy Volunteers

All

Include

Exclude

Found 452 clinical trials|View Analysis

Sort by:

Need a comprehensive medical report on "RNA"?

Analyze the latest clinical research and treatment options

Summarize scientific findings from medical journals

Tambua Mapema Plus - to Discover HIV Infection Early and Prevent Onward Transmission

Not Applicable

Completed

Conditions: HIV Infections

Interventions: Diagnostic Test: HIV-1 RNA testing

First Posted Date: 2018-04-26

Last Posted Date: 2023-11-13

Lead Sponsor: University of Oxford

Target Recruit Count: 2887

Registration Number: NCT03508908

Locations: 🇰🇪
KEMRI Mtwapa, Kilifi, Kenya

A TEst and Treat Intervention aMong Current People Who Inject Drugs With HCV Attending Needle and Syringe PrOgrams

Not Applicable

Completed

Conditions: Hepatitis C

Interventions: Device: HCV RNA Point of Care
Drug: Sofosbuvir/velpatasvir
Drug: Glecaprevir/pibrentasvir

First Posted Date: 2018-04-10

Last Posted Date: 2023-01-17

Lead Sponsor: Kirby Institute

Target Recruit Count: 101

Registration Number: NCT03492112

Locations: 🇦🇺
NUAA NSP, Sydney, New South Wales, Australia

RNA Sequencing Analysis in Large Vessel Occlusion Stroke DATA Bank

Not Applicable

Conditions: Stroke, Acute
Thrombosis

Interventions: Procedure: mechanical thrombectomy

First Posted Date: 2018-04-06

Last Posted Date: 2018-04-06

Lead Sponsor: Society of Minimally Invasive Neurological Therapeutic Procedures

Target Recruit Count: 370

Registration Number: NCT03490552

Locations: 🇪🇬
Alexandria University , School of medicine , Neurology Department, Neurovascular Unit, Alexandria, Egypt

Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer

Phase 1

Terminated

Conditions: Hepatocellular Cancer
Genitourinary Cancer
Melanoma
Colon Cancer
Gastrointestinal Cancer

Interventions: Biological: National Cancer Institute (NCI)-4650, a messenger ribonucleic acid (mRNA)-based, Personalized Cancer Vaccine

First Posted Date: 2018-03-29

Last Posted Date: 2020-06-02

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 5

Registration Number: NCT03480152

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation

Phase 2

Terminated

Conditions: Cerebral Cavernous Malformations

Interventions: Drug: Propranolol
Genetic: DNA and RNA Analysis

First Posted Date: 2018-03-22

Last Posted Date: 2024-04-19

Lead Sponsor: St. Joseph's Hospital and Medical Center, Phoenix

Target Recruit Count: 4

Registration Number: NCT03474614

Locations: 🇺🇸
Barrow Neurological Institute, Phoenix, Arizona, United States

Long Non Coding RNA HOTAIR and Midkine as Biomarkers in Thyroid Cancer

Conditions: Thyroid Cancer

Interventions: Other: complete blood picture ,serum urea and creatinine,liver function test,T3,T4,thyroid stimulating hormone,thyroglobuline and thyroglobuline anti body specific test Real time polymerase chain reaction

First Posted Date: 2018-03-19

Last Posted Date: 2018-03-19

Lead Sponsor: Assiut University

Target Recruit Count: 90

Registration Number: NCT03469544

HARE-40: HPV Anti-CD40 RNA vaccinE

Phase 1

Completed

Conditions: Human Papilloma Virus Related Carcinoma
Head and Neck Neoplasm
Cervical Neoplasm
Unknown Primary Tumors
Penile Neoplasms Malignant

Interventions: Drug: BNT113

First Posted Date: 2018-02-01

Last Posted Date: 2024-02-07

Lead Sponsor: University of Southampton

Target Recruit Count: 32

Registration Number: NCT03418480

Locations: 🇬🇧
Univeristy Hospitals Southampton NHS Foundation Trust, Southampton, Hampshire, United Kingdom
🇬🇧
The Christie NHS Foundation Trust, Manchester, United Kingdom

Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018)

Completed

Conditions: Vaccines
Physiological Effects of Drugs
Influenza, Human
Respiratory Tract Infections
Virus Diseases
RNA Virus Infections
Orthomyxoviridae Infections

Interventions: Biological: Seasonal Influenza Vaccine

First Posted Date: 2018-01-05

Last Posted Date: 2019-01-16

Lead Sponsor: Butantan Institute

Target Recruit Count: 403

Registration Number: NCT03392207

Locations: 🇧🇷
Crie - Unifesp, Sao Paulo, São Paulo, Brazil
🇧🇷
Avenida Vital Brasil 1500, Sao Paulo, Brazil

Evaluation the Association of Microbiome Between Respiratory Tract Samples and Stool Samples in Pneumonic Patients Accompanied by Respiratory Failure

Completed

Conditions: Pneumonia, Bacterial
Respiratory Failure
Microbiota
Lower Resp Tract Infection

Interventions: Diagnostic Test: 16s RNA sequence of sputum, bronchoalveolar lavage fluid (options), stool

First Posted Date: 2017-12-20

Last Posted Date: 2019-09-16

Lead Sponsor: Taichung Veterans General Hospital

Target Recruit Count: 200

Registration Number: NCT03379779

Locations: 🇨🇳
Taichung Veterans General Hospital, Taichung, Taiwan

Micro-RNA Expression Profiles in Localised Prostate Cancer

Withdrawn

Conditions: Prostate Cancer
Radical Prostatectomy

First Posted Date: 2017-11-09

Last Posted Date: 2023-12-12

Lead Sponsor: Wuerzburg University Hospital

Registration Number: NCT03338712

Prev
1
27
28
29
30
31
46
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy